Partner 5 – Shenzhen Institutes of Advanced Technology – CHINA
General description: Shenzhen Institutes of Advanced Technology (SIAT), a branch of the Chinese Academy of Science (CAS) in Southern China, was jointly established by Chinese Academy of Science, Shenzhen municipal government and Chinese University of Hong Kong in Feb, 2006. The SIAT engages in comprehensive and multi-disciplinary researches in several divisions. The team of SIAT has dramatically grown up from 5 in March, 2006 to 1529 employees at the end of 2011 and the staff is 918 researchers employees, including 13 IEEE Fellow, 2 CAS Academician, 12 talents in National one thousand plan, 3 leading Scientists of Guangdong, 341 talents with PhD degree and 224 of them with overseas studying/working experience.
Expertise: To meet the national needs in healthcare and manufacturing, SIAT sets its orientation towards the emerging industries of “new materials”, “low-cost healthcare”, “service robot”, “electric vehicle”, “cloud computing”, “digital city”, “Nano Medicine” and “new energy”.
Role in the project: The SIAT contributes to the RAPIDOS project by developing and optimizing PLGA/TCP porous scaffolds incorporating osteogenic factor or antibiotics using low-temperature rapid prototyping technology for bone repair. SIAT uses clinical imaging data to fabricate custom-made scaffold with suitable structure, mechanical properties and also biodegrade performance. Furthermore, the in vitro and in vivo osteogenesis and infection abilities are also be investigated using established animal models before clinical trials.
Key personnel: Prof. Ling Qin, Director of the Center for Translational Medicine Research and Development of Shenzhen Institutes of Advanced Technology, Chinese Academy of Science. Dr. Qin has been working on advanced diagnosis, prevention and treatment of musculoskeletal disorders and R&D of bioactive materials in collaboration with material scientists and engineers. Dr. Yuxiao Lai has been investigating biomedical materials for bone tissue engineering and performed fundamental research in cell-biomaterial interaction. Dr. Lai is a member of the Tissue Engineering International & Regenerative Medicine Society (TERMIS) and Chinese Society for Biomaterials (CSBM). Dr. Xinluan Wang has been working on application of scaffolds incorporating bioactive factors (TCM) on bone defect repair since working in SIAT.